J9 is a small molecule that reverses Dexamethasone (HY-14648) resistance in T-cell acute lymphoblastic leukemia. J9 is lethal to CUTLL1 cells only in the presence of Dexamethasone. J9 inhibits CUTLL1 cell growth with an EC50 of 28 µM in combination with Dexamethasone[1].
Molecular Weight:
212.25
CAS Number:
[947018-15-7]
Formula:
C12H12N4
Target:
Glucocorticoid Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
